2.125mg tirzepatide Overview certified practitioners 119.00 | Tirzepatide --- 18

According to the SmPC, these are classified as 'very common' (affecting more than 1 in 10 people)

Cardiovascular benefits of GLP-1 receptor agonists in patients living with obesity or overweight: A meta-analysis of randomized controlled trials

doi: 10.1007/S11250-008-9146-1/FIGURES/1 9 AyyatM

Abdominal-Symptom Evaluation Severe or persistent abdominal symptoms should be evaluated medically rather than managed through routine self-testing

Evidencia clnica Actualmente tenemos evidencia muy limitada que respalde el uso de medicamentos GLP-1 o duales GIP/GLP-1 en el tratamiento de adultos con diabetes tipo 1

Their role in health and disease